Mon panier

latent GDF-8

latent GDF-8 Informations sur la molécule

Nom anglaisGrowth/differentiation factor 8Nombre de médicaments commercialisés0
Nombre de médicaments cliniques6Alias de la cibleMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Phase de R&D la plus avancéeNDA/BLA
Nom anglaisGrowth/differentiation factor 8
Alias de la cibleMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques6
Phase de R&D la plus avancéeNDA/BLA

Demande de produit

latent GDF-8Contexte de la molécule

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

latent GDF-8Alias de la molécule

latent GDF-8

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb CompanyMuscular Dystrophy, Duchenne; Neuromuscular Diseases; Muscular Atrophy, Spinal
Details
RO-7204239GYM-329; RO-7204239; RG-6237; RG-70240Phase 3 ClinicalF. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co LtdMuscular Dystrophy, Facioscapulohumeral; Muscular Atrophy, Spinal
Details
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals IncMyositis, Inclusion Body; Obesity; Sarcopenia
Details
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S HospitalBecker muscular dystrophy; Myositis, Inclusion Body; Muscular Dystrophy, Duchenne
Details
KER-065KER-065; RKER-065Phase 1 ClinicalKeros Therapeutics IncNeuromuscular Diseases; Obesity
Details
HS135HS-135Phase 1 Clinical35Pharma IncHypertension, Pulmonary; Heart Failure, Diastolic; Pulmonary Arterial Hypertension
Details
  • Informations sur la molécule
  • Demande de produit
  • Informations sur les médicaments cliniques